ISRCTN66955626已完成不适用
on-interventional study on the subcutaneous application of gammanorm®
Octapharma GmbH (Germany)0 个研究点目标入组 100 人开始时间: 2014年9月23日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •Patients of any gender and age, who receive treatment with gammanorm®
排除标准
- •Hypersensitivity to any of the components
研究者
相似试验
已完成
1 期
Clinical study with subsequent subcutaneous administration of GEN0101 in the patients enrolled in the Phase 1 dose-escalation, safety / tolerability and preliminary efficacy study of intratumoral and subcutaneous administration of GEN0101 (GEN0101-JM003).JPRN-UMIN000026892Osaka University Hospital, Center for respiratory6
已完成
不适用
Evaluation of the effect of Carrogated drain in reducing SSICondition 1: Acute abdomen. Condition 2: Acut peritonitis. Condition 3: Biliary peritonitis. Condition 4: Fecal peritonitis.Acute abdomenR10.0PeritonitisIRCT20201022049115N1Tehran University of Medical Sciences158
招募中
2 期
A Study of Ketamine in Elderly Patients with Depression.DepressionACTRN12617001130358niversity of Otago24
未知
3 期
An open-label study of subcutaneous injection (s.c.) S-811717 (oxycodone hydrochloride solution for injection) in patients with cancer paiJPRN-jRCT2080220763SHIONOGI & CO., LTD.
进行中（未招募）
1 期
Subcutaneous verus intravenous morphine in palliative cancer patientsCancer pain not responding to oral opioids in palliative cancer patient, where switching to the parenteral route is indicated.EUCTR2021-003427-14-NOAkershus University Hospital60